News about Alois Alzheimer

Scientists backed by billions of pounds are now, one step closer to thwarting Alzheimer's disease, according to decades of painful study. Although a cure has so far escaped pharmaceutical companies, game-changing drugs that stop the memory-robbing disease in its tracks have appeared (left graph). However, one problem remains: diagnosing Alzheimer's can be very difficult. Patients must perform a slew of tests, including scans and lumbar puncture, with some requiring waits of up to four years for their diagnosis, while others die before being told they have the disorder. That's why top neurologists are so excited by the new medical breakthrough, which is a simple blood test that can often detect Alzheimer's disease in the brain up to 15 years before symptoms appear.

Since the drug was discovered to slow cognitive decline in Alzheimer's in the 1980s, Europe, and Asia, scientists have spent more than a century struggling with the disease that robs people of their identity and self-determination. Lecanemab's groundbreaking trial findings, which show that it can both slow cognitive decline and investigate what is believed to be the root cause, were published today as the 'beginning of the end' for Alzheimer's. World-renowned experts, who are on the lookout for a way to reverse the memory-robbing disorder's course after years of punishing setbacks, have also named it the 'true deal,', and Professor John Hardy is hopeful of finding a cure.